STOCK TITAN

Cronos Group Inc - CRON STOCK NEWS

Welcome to our dedicated news page for Cronos Group (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cronos Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cronos Group's position in the market.

Rhea-AI Summary
<p>Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announces the virtual 2024 Annual Meeting of Shareholders on June 20, 2024, at 11:00 a.m. ET. The meeting will be held online via live audio webcast, allowing registered shareholders and proxyholders to participate regardless of location.</p>
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Cronos Group Inc. will host its 2024 First Quarter Earnings Conference Call on May 9, 2024, where senior management will discuss financial results and take questions from investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Cronos Group Inc. launches Lord Jones® Chocolate Fusions, its first entry into the chocolate edibles category. The bite-sized chocolates feature a multi-texture experience and three delicious flavor combinations. Each package contains five pieces with 2mg of THC per piece, offering a decadent sweet treat for adult cannabis consumers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.6%
Tags
none
Rhea-AI Summary
Cronos Group Inc. announces Mike Gorenstein, Chairman, President, and CEO, to speak at the 36th Annual Roth Conference. The webcast will be live on March 18, 2024, at 8:30 AM PT.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.54%
Tags
conferences
-
Rhea-AI Summary
Cronos Group Inc. ended 2023 with $862 million in cash, saw a 9% increase in net revenue in Q4 2023, and launched the Lord Jones brand in Canada. The Spinach brand became the number two brand in Canada. The Company exited its U.S. hemp-derived CBD operations in Q2 2023. Consolidated net revenue for 2023 was $87.2 million, with a gross profit of $11.9 million. Adjusted EBITDA for 2023 was $(61.6) million. Cronos achieved $30 million in savings in 2023 and expects further savings in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.96%
Tags
none
-
Rhea-AI Summary
Cronos Group Inc. will hold its 2023 fourth quarter and full-year earnings conference call on February 29, 2024. The senior management team will discuss financial results and take questions from the investment community. Participants can register online for the webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.27%
Tags
Rhea-AI Summary
Cronos Group Inc. announced that its brand, Spinach®, closed 2023 as the number one ranked flower brand in Canada with a 6.9% market share in the fourth quarter. The Spinach® flower products have resonated strongly with consumers, leading to a significant increase in its ranking from the fourth best-selling flower brand in 2022, to become the best-selling flower brand in Canada in 2023. The Spinach® product portfolio is ranked as the second best-selling cannabis brand in Canada across all categories as of December 2023. In 2023, Spinach® products held a number 1 position in the flower and edibles categories, and a top-10 ranking in the pre-rolls and vape categories. The Spinach® team successfully launched six new flower SKUs and seven new pre-roll SKUs in 2023. Cronos’ sophisticated breeding program and unique portfolio of genetics has helped the Company win in the highly competitive Canadian market, as well as expand Cronos’ international footprint with distribution to the growing markets in Germany and Australia.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
none
-
News
Rhea-AI Summary
Cronos Group Inc. (CRON) expands distribution into the Australian market with its first shipment of cannabis flower to Vitura Health Limited (VIT). Cronos owns approximately 10% of the common shares of Vitura and will supply cannabis for Vitura. The Australian medical cannabis market has seen impressive growth in patient approvals and sales, and Cronos aims to help establish Vitura as a leading cannabis brand in Australia.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.02%
Tags
none
-
Rhea-AI Summary
Cronos Group Inc. (CRON) launches Lord Jones® Live Resin Vapes, featuring curated strains, pure live resin, and high-quality hardware. The products offer a multi-dimensional, true-to-plant experience with THC levels exceeding 70%. The vapes are available in two hardware options and versatile sizing options, catering to both enthusiasts and new consumers. The products will be available in select Canadian provinces in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.5%
Tags
none
Rhea-AI Summary
Cronos Group Inc. (CRON) announced the sale and leaseback of its Peace Naturals Campus to Future Farmco Canada Inc. for C$23 million cash, aiming to reduce costs and improve the gross margin profile of the business. The transaction is subject to certain conditions and is expected to close within 30 calendar days after all conditions are satisfied or waived.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.88%
Tags
none
Cronos Group Inc

Nasdaq:CRON

CRON Rankings

CRON Stock Data

961.04M
203.49M
46.57%
13.1%
1.46%
Medicinal and Botanical Manufacturing
Manufacturing
Link
Canada
Toronto

About CRON

cronos group is a globally diversified and vertically integrated cannabis company with a presence across four continents. the company operates two wholly-owned canadian licensed producers regulated under health canada’s access to cannabis for medical purposes regulations: peace naturals project inc. (ontario), which was the first non-incumbent medical cannabis license granted by health canada, and original bc ltd. (british columbia), which is based in the okanagan valley. the company has multiple international production and distribution platforms: cronos israel and cronos australia. through an exclusive distribution agreement, cronos also has access to over 12,000 pharmacies in germany as the company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.